BNY Mellon Global Equity Income Fund USD B IncRegister to Unlock Ratings |
Performance History | 29/02/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 0.9 | 14.7 | 7.8 | 3.9 | 1.7 | |
+/-Cat | -1.0 | -3.6 | 8.6 | -3.4 | -1.3 | |
+/-B’mrk | - | -5.7 | 1.0 | -0.8 | -1.0 | |
Category: Global Equity Income | ||||||
Category Benchmark: Morningstar Gbl High Div Yl... |
Key Stats | ||
NAV 28/03/2024 | USD 1.92 | |
Day Change | - | |
Morningstar Category™ | Global Equity Income | |
ISIN | IE00B3T34201 | |
Fund Size (Mil) 29/02/2024 | USD 441.73 | |
Share Class Size (Mil) 28/03/2024 | USD 4.06 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 24/11/2023 | 1.63% |
Investment Objective: BNY Mellon Global Equity Income Fund USD B Inc |
The objective of the Sub-Fund is to aim to generate annual distributions and to achieve long-term capital growth by investing predominantly in equity and equity-related global securities. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Jonathan Bell 01/04/2020 | ||
James Lydotes 10/02/2023 | ||
Click here to see others | ||
Inception Date 29/07/2010 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
FTSE World TR USD | Morningstar Gbl High Div Yld NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for BNY Mellon Global Equity Income Fund USD B Inc | 31/01/2024 |
|
|
Top 5 Holdings | Sector | % |
Sanofi SA | Healthcare | 3.46 |
CME Group Inc Class A | Financial Services | 3.32 |
Medtronic PLC | Healthcare | 3.17 |
AbbVie Inc | Healthcare | 2.85 |
Publicis Groupe SA | Communication Services | 2.81 |
Increase Decrease New since last portfolio | ||
BNY Mellon Global Equity Income Fund USD B Inc |